1 / 32

Atrophic Rhinitis ’ Ozena ’

Atrophic Rhinitis ’ Ozena ’. Bastaninejad , Shahin , MD, ORL & HNS, TUMS Amiralam Hospital. Presentation Outlines. Definition Pathophysiology Clinical presentations Differential diagnosis Investigations Treatment.

gay-berry
Download Presentation

Atrophic Rhinitis ’ Ozena ’

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Atrophic Rhinitis’Ozena’ Bastaninejad, Shahin, MD, ORL & HNS, TUMS Amiralam Hospital

  2. Presentation Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment

  3. Atrophic rhinitis (AR) is a chronic and degenerative disease of the nasal & paranasal mucosa & other structures

  4. Definition (Cont’) • triad of characteristic fetor, greenish crusts and roomy nasal cavitiesthis triad is diagnostic of the condition • Prevalence of Primary AR0.3-1% in high prevalence countries • High Prevalence countries are: India, Pakistan, China, Philippines, Malaysia, Saudi Arabia, Egypt and South america

  5. Definition (Cont’) • Primary AR: More common in females(*6), usually bilateral, Prevalent in young and middle age adults • Often, no underlying etiology is discovered, although inheritable or infectious causes (58.7% K. ozena) are proposed mechanisms • there is however little evidence to suggest bacterial organisms cause the disease, they may be secondary invaders

  6. Definition (Cont’) • Secondary AR: • Complication of sinus surgery (89%) • FESS in CRS > FESS in Polypoid CRS • In Mayo clinic assay : Partial MT and/or IT resection was the most common cause • Complication of radiation (2.5%) • Following nasal trauma (1%) • Sequela of granulomatous diseases (1%) and other infections : TB, Sarcoidosis, Leprosy, Rhinoscleroma, Syphilis

  7. Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment

  8. Pathophysiology • Nl. Respiratory epithelium (Pseudostratified Columnar) metaplastic changes cuboidal/stratified squamous epithelium • Atrophy of cilia and the mucosal and submucosalgland • Secondary bac. Infection produce a foetidodour • Osteitis of inferior turbinates and ethmoidturbinates • Vascular involvement (mainly endarteritisobliterans)

  9. Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment

  10. Clinical Features (Symptoms) • Nose emits a foul smell due to crusting and secondary infections (main characteristic). • Anosmia, cacosmia • Nasal obstruction • Headache • Thick purulent discharge with a foul smell (due to the anaerobic bacteria) • Minor bleeds due to dislodgment of crusts • Complain of dryness in the nose and throat (pharyngitissicca)

  11. Clinical Features (signs) • Greenish yellow and black crusts (Crusts 100% present), bleeding and ulcerated mucosa is seen when crusts are separated • Patient is usually gloomy • Foetor (detected from distance) • Wide capacity of the nasal passages, Shrinkage of inferior and middle turbinates • Insensitivity of nasal mucosa (probe test) • Septal perforation, myiasis, saddle nose &… may be seen

  12. Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment

  13. Differential diagnosis • TB • Leprosy • Scleroma • Syphilis • Chronic sinus suppuration on its own • Suppurating adenoidal disease • Neglected FB / rhinoliths • Wegner’s disease • Chronic fungal rhinosinusitis • Empty nose syndrome (ENS) Kern & Stenkvist at 1994

  14. What is ENS? ENS is an iatrogenic disorder most often recognized by thepresence of paradoxical nasal obstruction despite an objectively wide nasal fossa

  15. ENS vs. Secondary AR • The resorption of the turbinate and adjacent mucosal tissue that results from atrophic rhinitis is reflective of the underlying pathophysiology of the disease, whereas ENS is an iatrogenic disorder • Secondary AR may also be the result of a multitude of other factors, including trauma, infection, or immunologic disorders. • Atrophic rhinitis has clear pathogenic links to organisms isolated from nasal cultures, but as of yet, there is no pathogen associated with ENS

  16. Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment

  17. Investigations • Hematologic study (CBC/diff) • ESR • FBS • C-ANCA, VDRL • PPD • CXR • PNS CT-Scan • Nasal swab for culture • Nasal Bx tested for bacteriological and morphological indices

  18. Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment

  19. Treatment (Medical) • Conservative management is the mainstay of the treatment • No cure available • Decongestants or antihistamines: strongly contraindicates • Nasal irrigation and douches: • With Alkaline douches (preferred) • With N/S or antibiotic+N/S douches

  20. Treatment (Medical) • An ideal alkaline nasal douche mixture: • Sodium bicarbinate 25g • Sodium biborate 25g • Sodium chloride 50g • One teaspoonful of this mixture in 250cc lukewarm water, tds or qid, for 6wk, with a 10 to 20cc syringe • Instruct the patient to bend forward during the procedure and keep saying K K K…

  21. Treatment (Medical) • Glucose-glycerine nose drops • Anhydrous Glucose 25% (~15g) • Glycerine 60cc • Use this after nasal douching • You can also use Gentamicin or Chloramphenicol drops after nasal douching, too

  22. Treatment (Medical) • Antibiotics: • Rifampicin 600mg daily for 12wk (generic cap. is 300mg – take 2 every morning) • Recently: Cipro 500-750mg bid for 1-3mo • Vitamin A , 12,500 IU/day up to two weeks. • Iron supplements (if the patient is anemic)

  23. Treatment (Surgical) • Young’s Procedure • Modified Young’s procedures • Modification of modified Young • Implantation • Other approaches

  24. Treatment(Surgical) • Young’s procedure • Circumferential flap elevation 1 cm cephalic to the alar rim • Complete closure of nostril • Staged second side in 3-6 months • Difficult to elevate circumferential flap

  25. Modified Young • Staged second side with first side takedown in 6 mo • No vestibular stenosis on takedown

  26. Treatment (Surgical) • Modification of the modified young’s:

  27. Treatment (Surgical) • Implantation: uses Bone (Auto/homografts), Cartilages, ... Prostethic implants such as Plastipore, ... • Extrusion of the prosthetic implants occured 1 in 8 in Plastipore series, but in another prosthetic series it was occured as high as 80%

  28. Plastipore

  29. Silastic Sheet - Case: Primary AR - 12mopostop result (Otolaryngology–Head and Neck Surgery (2010)) Right Left

  30. Treatment (surgical) • Other approaches: • Transferring the Stensen duct to the maxillary sinus antrum • Using a caldwell approach, translocating the lateral nasal wall more medially • Silastic obturator • ...

  31. Presentation Conclusion Endoscopic Sinus Surgery Primary Atrophic Rhinitis 2ndAtrophic Rhinitis Functional Endoscopic Sinus Surgery ...Try to save nasal structures and mucosal layer as much as you can

  32. Thank You!

More Related